Navigation Links
National Heart Lung and Blood Institute creates national network to study cardiovascular disease

November 28, 2007 (Oakland, CA) The National Heart Lung and Blood Institute has provided $7.5 million over the next five years to establish a collaborative Cardiovascular Research Network, a national resource that will leverage the collective cardiovascular expertise, diverse community-based study populations and rich electronic data systems within Kaiser Permanente and eight other health plans in the HMO Research Network to better study the epidemiology, prevention, management and outcomes of cardiovascular diseases.

"This is the first research network that will be able to follow patients longitudinally - their care, medications, hospitalizations and vital status - which can directly lead to improvements in care delivery and patient outcomes, said Dr. John Rumsfeld, Chief Science Officer for the American College of Cardiology National Cardiovascular Data Registries. The combination of working with existing American College of Cardiology and American Heart Association clinical registries to follow patients' care and outcomes over time, as well as creating new registries where they dont already exist, is very powerful."

Despite advances in diagnosis and treatment of cardiovascular disease, it remains the leading cause of death and disability in the United States and one of the fastest rising causes of death and disability in the world. Led by Kaiser Permanente Division of Research investigator Alan S. Go, MD, the new CVRN network will initially conduct three core research projects over the next five years: 1) hypertension recognition, treatment and control 2) quality of care and outcomes of the blood thinner, warfarin, for atrial fibrillation and blood clots 3) and the use and outcomes of implantable cardiac defibrillators.

The goal of our collaborative network is to set up a structure and organize our research expertise to more rapidly study emerging cardiovascular research questions and to facilitate productive collaborations with other researchers and organizations that ultimately maximize the delivery of appropriate care and optimize outcomes for those with or at risk for cardiovascular disease, said Alan S. Go, MD, a senior investigator with the Kaiser Permanente Division of Research who is the CVRN Principal Investigator.

The CVRN will leverage expertise, populations, and data resources from a consortium of 14 geographically diverse health plans in the United States with integrated research divisions. Collectively, this represents more than 7 million health plan members and several hundred doctoral level investigators, clinical researchers and support people.

"The goal of the CVRN is to increase knowledge about cardiovascular disease prevention and treatment in the context of community-based health care delivery, an environment in which most clinical and preventive care is delivered," said NHLBI Director Elizabeth G. Nabel, MD. "Through the collaboration of several health plans across the United States, this research network will help us understand the integration of scientific advances into clinical practice."'


Contact: Danielle Cass
Kaiser Permanente Division of Research

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... Association meeting in Washington D.C. revolved around the fact that proper dental care, both ... talk stressed the link between periodontal disease (more commonly referred to as gum disease) ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... be a safe and convenient way to dispense prescription medications at home, so ... and effective way to monitor and dispense prescription medications. In doing so, it ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term Support) ... supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... , November 26, 2015 ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... has found that immunotherapy can be efficiently combined ...
Breaking Medicine Technology: